NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nyxoah SA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$0.95−0.16 (-14.05%)
Close on Oct 19, 2026
Share price
−$4.8459 (−83.55%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -€90.09M
- EPS, diluted
- -2.36 EUR
- Free cash flow
- -€69.78M
- Book value per share
- 1.46 EUR
- Diluted shares
- 57M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Eight years at a glance
Fiscal years 2018 to 2025, EUR
Gross profit
€6.33M+113.1% YoY
Operating income
-€83.49M
Net income
-€90.09M
EPS, diluted
-2.36 EUR
Free cash flow
-€69.78M
Reported period